BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38008762)

  • 21. Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy.
    Hang D; Schaff HV; Ommen SR; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2096-2102. PubMed ID: 29153286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
    Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
    Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midterm Outcome of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy (HOCM): A Single-Center Observational Study.
    Islam Talukder MQ; DasGupta S; Uddin M; Syed Al Manzoo I; Ziaur Rahman M; Rahman ATMK; Ahmed F
    Heart Surg Forum; 2020 Nov; 23(6):E873-E879. PubMed ID: 33234192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional Left Ventricular Reverse Remodeling After Myectomy in Hypertrophic Cardiomyopathy.
    Wang J; Sun X; Xiao M; Zhang M; Chen H; Zhu C; Wang S; Wang H
    Ann Thorac Surg; 2016 Jul; 102(1):124-31. PubMed ID: 27021034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.
    Fang H; Tang H; Li P; Xiong L; Hu G; Li L; Yu Y; Zhao B
    Echocardiography; 2017 Mar; 34(3):407-414. PubMed ID: 28130861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.
    Finocchiaro G; Haddad F; Kobayashi Y; Lee D; Pavlovic A; Schnittger I; Sinagra G; Magavern E; Myers J; Froelicher V; Knowles JW; Ashley E
    Echocardiography; 2016 May; 33(5):686-94. PubMed ID: 26926154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of epicardial adipose tissue volume assessed by cardiac magnetic resonance for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Zhou Y; Yu M; Cui J; Hu F; Yang Z; Yuan J; Qiao S
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1383-1393. PubMed ID: 33392874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
    Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
    J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy.
    Yamabe T; Ginns J; Vedula V; Leb JS; Shimada YJ; Weiner SD; Takayama H
    JTCVS Open; 2022 Sep; 11():105-115. PubMed ID: 36172435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
    Meghji Z; Nguyen A; Fatima B; Geske JB; Nishimura RA; Ommen SR; Lahr BD; Dearani JA; Schaff HV
    JAMA Cardiol; 2019 Mar; 4(3):237-245. PubMed ID: 30810698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
    Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
    [No Abstract]   [Full Text] [Related]  

  • 38. THE PLACE OF CARDIAC COMPUTED TOMOGRAPHY IN PREOPERATIVE PLANNING OF EXTENDED SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE FORM OF HYPERTROPHIC CARDIOMYOMATHY.
    Tregubova MO; Rudenko KB; Lazoryshynets VV; Fedkiv SV; Trembovetskaya OM; Danchenko PA; Vitkovsky YI; Ishchenko MS; Gavrylyshyn AY; Parfentyeva VV; Stukov YY
    Probl Radiac Med Radiobiol; 2020 Dec; 25():592-606. PubMed ID: 33361864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical septal myectomy for hypertrophic cardiomyopathy. The Iranian experience.
    Ghavidel AA; Alizadehasl A; Khalilipur E; Amirghofran A; Nezhadbahram H; Azarfarin R
    Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):64-73. PubMed ID: 34605707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy.
    Deb SJ; Schaff HV; Dearani JA; Nishimura RA; Ommen SR
    Ann Thorac Surg; 2004 Dec; 78(6):2118-22. PubMed ID: 15561048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.